Scilit logo
  • Rankings
  • Search Publications
    Cited-by Search
  • Sources
  • Publishers
  • Scholars
    Top Cited Scholars
  • Organizations
  • Scilit
    About Us
    Advisory Board
    Data Sources
    Career
    Support / Contact
    User Guide
    Publisher User
    Search Function
    Rankings Function
    API Resource
    Scilit Knowledge
    Metrics
    Scilit Recognitions
    Publications Classification
    Media
    News
    Blog
Register
  1. Home
  2. Publications
  3. Figure S5 from Recharacterization of the Tumor Suppressive Mechanism of RSL3 Identifies the Selenoproteome as a Druggable Pathway in Colorectal Cancer
  1. Home
  2. Publications
  3. Figure S5 from Recharacterization of the Tumor Suppressive Mechanism of RSL3 Identifies the Selenoproteome as a Druggable Pathway in Colorectal Cancer

Figure S5 from Recharacterization of the Tumor Suppressive Mechanism of RSL3 Identifies the Selenoproteome as a Druggable Pathway in Colorectal Cancer

Authors:
  • SDStephen L. DeAngelo
    Stephen L. DeAngelo
  • LZLiang Zhao
    Liang Zhao
  • SDSofia Dziechciarz
    Sofia Dziechciarz
  • MSMyungsun Shin
    Myungsun Shin
  • SSSumeet Solanki
    Sumeet Solanki
  • ABAndrii Balia
    Andrii Balia
  • MEMarwa O. El-Derany
    Marwa O. El-Derany
  • CCCristina Castillo
    Cristina Castillo
  • YQYao Qin
    Yao Qin
  • NDNupur K. Das
    Nupur K. Das
  • HBHannah N. Bell
    Hannah N. Bell
  • Joao A. Paulo
    Joao A. Paulo

Open Access
Publisher website
Google Scholar
  • 1 August 2025
    • other
    • Published by American Association for Cancer Research (AACR)
    • DOI:10.1158/0008-5472.29761163
Abstract
Supplementary Figure S5 shows oxidative stress markers, apoptosis, systemic toxicity, and histological outcomes following in vivo auranofin treatments in mouse models.
Keywords
  • CELL DEATH AND SENESCENCE
  • FERROPTOSIS
  • CHEMISTRY & CHEMICAL BIOLOGY
  • DRUG MECHANISMS
  • CELLULAR RESPONSES TO ANTICANCER DRUGS
  • GASTROINTESTINAL CANCERS
  • COLORECTAL CANCER
Scilit logo

Have questions? Email us at support@scilit.com

© 2026 MDPI (Basel, Switzerland) unless otherwise stated.

MDPI initiatives

  • MDPI Journals
  • MDPI Books
  • Sciforum
  • Proceedings Series
  • Preprints.org
  • SciProfiles
  • Encyclopedia
  • JAMS

Legal

  • Privacy
  • Terms
  • About
  • Contact
  • Disclaimer

Follow us

  • facebook icon
  • x icon
  • linkedin icon

Join us

  • Career

© 2026 MDPI (Basel, Switzerland) unless otherwise stated.